X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-11-25 | NRDY | Nerdy Inc. | Cohn Charles K. | CEO, 10% | P - Purchase | $1.16 | +119,242 | 55,712,036 | 0% | +$138,321 | ||||||
2025-11-25 | DMLP | Dorchester Minerals, L.P. | Vaughn Robert C | Dir | P - Purchase | $21.41 | +4,615 | 540,353 | +1% | +$98,800 | ||||||
2025-11-25 | DMLP | Dorchester Minerals, L.P. | Moriyama Leslie A | CFO | P - Purchase | $21.50 | +3,041 | 83,673 | +4% | +$65,382 | ||||||
2025-11-25 | GLSI | Greenwich Lifesciences, Inc. | Patel Snehal | CEO, CFO, 10% | P - Purchase | $8.37 | +4,600 | 5,588,102 | 0% | +$38,502 | ||||||
2025-11-25 | GCTS | Gct Semiconductor Holding, Inc. | Shin Hyunsoo | Class II Director | P - Purchase | $1.28 | +16,725 | 757,771 | +2% | +$21,408 | ||||||
2025-11-25 | ICCC | Immucell Corp /De/ | Tomsche David Scott | Dir | P - Purchase | $4.76 | +3,266 | 131,387 | +3% | +$15,554 | ||||||
2025-11-25 | MAIA | Maia Biotechnology, Inc. | Vitoc Vlad | CEO, 10% | P - Purchase | $0.97 | +10,500 | 1,041,421 | +1% | +$10,144 | ||||||
2025-11-25 | MAIA | Maia Biotechnology, Inc. | Luput Cristian | Dir | P - Purchase | $0.98 | +10,000 | 399,483 | +3% | +$9,785 | ||||||
2025-11-26 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.99 | +4,000 | 1,730,651 | 0% | +$3,975 | ||||||
2025-11-26 | BLNE | Beeline Holdings, Inc. | Freedman Joseph David | Dir | P - Purchase | $1.85 | +1,000 | 364,891 | 0% | +$1,850 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |